Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Veganic Skn Limited is currently processing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single pending action comprises the company's entire active prosecution profile as provided in the data. The workload is situated within 1 distinct art unit, indicating a narrow technical scope for the company's current patenting activities in this field.
The busiest examiner for this portfolio is ROBERTS, LEZAH, who is responsible for 1 pending office action. Since there is only 1 distinct examiner involved in the portfolio, this individual manages all of the company's current pending matters. The alignment of 1 pending office action with 1 examiner and 1 art unit suggests a highly focused prosecution environment. For practitioners, this means that the outcome of the company's current patent efforts relies entirely on the decisions made by this single examiner. The lack of multiple examiners or art units for the 1 pending action simplifies the administrative tracking but centralizes the prosecution risk.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBERTS, LEZAH | 1 | 48.6% | +35.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17906584 | Antiviral Composition for Oral Care | ROBERTS, LEZAH | 28d |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17906584 | Antiviral Composition for Oral Care | ROBERTS, LEZAH | 1612 | §103 | Non-Final OA | 28d | Pending | Sep 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVeganic Skn Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Lezah Roberts has the most, with 1 of Veganic Skn Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
